diminazene aceturate has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apostolopoulos, V; Egom, EE; Gadanec, LK; Kruzliak, P; Kubatka, P; Levinger, I; McSweeney, KR; Qaradakhi, T; Rimarova, K; Rodrigo, L; Tacey, A; Zulli, A | 1 |
1 review(s) available for diminazene aceturate and Neoplasms
| Article | Year |
|---|---|
The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cardiovascular Diseases; Diminazene; Enzyme Activation; Enzyme Activators; Humans; Neoplasms; Renin-Angiotensin System | 2020 |